Gary E. Archer

Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma

John H. Sampson, Amy B. Heimberger, Gary E. Archer et al. · Journal of Clinical Oncology · 2010 · 808 citations · Full text

Medicine, Immunology, Oncology +17

Increased Regulatory T-Cell Fraction Amidst a Diminished CD4 Compartment Explains Cellular Immune Defects in Patients with Malignant Glioma

Peter E. Fecci, Duane A. Mitchell, John F. Whitesides et al. · Cancer Research · 2006 · 620 citations

Life Sciences, Immunology, Oncology +17

Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients

Duane A. Mitchell, Kristen A. Batich, Michael D. Gunn et al. · Nature · 2015 · 524 citations · Full text

Medicine, Immunology, Oncology +16

Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma.

Peter A. Humphrey, Albert J. Wong, Bert Vogelstein et al. · Proceedings of the National Academy of Sciences · 1990 · 383 citations

Medicine, Molecular Biology, Oncology +17

Systemic CTLA-4 Blockade Ameliorates Glioma-Induced Changes to the CD4+ T Cell Compartment without Affecting Regulatory T-Cell Function

Peter E. Fecci, Hidenobu Ochiai, Duane A. Mitchell et al. · Clinical Cancer Research · 2007 · 346 citations

Life Sciences, Immunology, Oncology +17